{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:13:40Z","timestamp":1787242420459,"version":"build-2736575974"},"reference-count":40,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2017,4,30]]},"abstract":"<jats:p>Gestational diabetes mellitus (GDM) and polycystic ovary syndrome (PCOS) are distinct pathologies with impaired insulin sensitivity as a common feature. The aim of this study was to evaluate the response of fat tissue adipokines and gastrointestinal incretins to glucose load in patients diagnosed with one of the two disorders and to compare it with healthy controls. Oral glucose tolerance test (oGTT) was performed in 77 lean young women: 22 had positive history of GDM, 19 were PCOS patients, and 36 were healthy controls. Hormones were evaluated in fasting and in 60 min intervals during the 3 h oGTT using Bio-Plex ProHuman Diabetes 10-Plex Assay for C-peptide, ghrelin, GIP, GLP1, glucagon, insulin, leptin, total PAI1, resistin, visfatin and Bio-Plex ProHuman Diabetes Adipsin and Adiponectin Assays (Bio-Rad). Despite lean body composition, both PCOS and GDM women were more insulin resistant than controls. Significant postchallenge differences between the GDM and PCOS groups were observed in secretion of adipsin, leptin, glucagon, visfatin, ghrelin, GIP, and also GLP1 with higher levels in GDM. Conversely, PCOS was associated with the highest resistin, C-peptide, and PAI1 levels. Our data suggest that decreased insulin sensitivity observed in lean women with GDM and PCOS is associated with distinct hormonal response of fat and gastrointestinal tissue to glucose load.<\/jats:p>","DOI":"10.33549\/physiolres.933366","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T06:32:30Z","timestamp":1576823550000},"page":"283-292","source":"Crossref","is-referenced-by-count":20,"title":["Distinct Response of Fat and Gastrointestinal Tissue to Glucose in Gestational Diabetes Mellitus and Polycystic Ovary Syndrome"],"prefix":"10.33549","author":[{"given":"D.","family":"VEJRAZKOVA","sequence":"first","affiliation":[{"name":"Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"LISCHKOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"VANKOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"STANICKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"VRBIKOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"LUKASOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"VCELAK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"VACINOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"BENDLOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2017,4,16]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"AHMED MB, ISMAIL MI, MEKI AR: Relation of osteoprotegerin, visfatin and ghrelin to metabolic syndrome in type 2 diabetic patients. Int J Health Sci 9: 127-139, 2015.","DOI":"10.12816\/0024107"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"AHREN B: Beta- and alpha-cell dysfunction in subjects developing impaired glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women. Diabetes 58: 726-731, 2009.","DOI":"10.2337\/db08-1158"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"AZIZ M, SIDELMANN JJ, FABER J, WISSING ML, NAVER KV, MIKKELSEN AL, NILAS L, SKOUBY SO: Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes. Acta Obstet Gynecol Scand 94: 1082-1089, 2015.","DOI":"10.1111\/aogs.12706"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"BENEDICT C, SHOSTAK A, LANGE T, BROOKS SJ, SCHI\u00d6TH HB, SCHULTES B, BORN J, OSTER H, HALLSCHMID M: Diurnal rhythm of circulating nicotinamide phosphoribosyltransferase (Nampt\/visfatin\/PBEF): impact of sleep loss and relation to glucose metabolism. J Clin Endocrinol Metab 97: E218-E222, 2012.","DOI":"10.1210\/jc.2011-2241"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"BINDER BR, CHRIST G, GRUBER F, GRUBIC N, HUFNAGL P, KREBS M, MIHALY J, PRAGER GW: Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci 17: 56-61, 2002.","DOI":"10.1152\/nips.01369.2001"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"BOUCHARD L, VOHL MC, LEBEL S, HOULD FS, MARCEAU P, BERGERON J, P\u00c9RUSSE L, MAURI\u00c8GE P: Contribution of genetic and metabolic syndrome to omental adipose tissue PAI-1 gene mRNA and plasma levels in obesity. Obes Surg 20: 492-499, 2010.","DOI":"10.1007\/s11695-010-0079-1"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"CASSAR S, TEEDE HJ, HARRISON CL, JOHAM AE, MORAN LJ, STEPTO NK: Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity. Clin Endocrinol (Oxf) 83: 50-58, 2015.","DOI":"10.1111\/cen.12619"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"CEDERNAES J, SCHI\u00d6TH HB, BENEDICT C: Determinants of shortened, disrupted, and mistimed sleep and associated metabolic health consequences in healthy humans. Diabetes 64: 1073-1080, 2015.","DOI":"10.2337\/db14-1475"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"CHEDRAUI P, P\u00c9REZ-L\u00d3PEZ FR, ESCOBAR GS, PALLA G, MONTT-GUEVARA M, CECCHI E, GENAZZANI AR, SIMONCINI T; RESEARCH GROUP FOR THE OMEGA WOMEN'S HEALTH PROJECT: Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas 79: 86-90, 2014.","DOI":"10.1016\/j.maturitas.2014.06.008"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"DEMARCO VG, SOWERS JR: Ghrelin: a new incretin enhancer therapy? Diabetes 64: 1500-1502, 2015.","DOI":"10.2337\/db14-1871"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"FANTUZZI G, FAGGIONI R: Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 68: 437-446, 2000.","DOI":"10.1189\/jlb.68.4.437"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"FARSHCHIAN F, RAMEZANI TF, AMIRRASOULI H, RAHIMI PH, HEDAYATI M, KAZEROUNI F, SOLTANI A: Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome. Int J Endocrinol Metab 12: e15503, 2014.","DOI":"10.5812\/ijem.15503"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"FERREIRA AF, REZENDE JC, VAIKOUSI E, AKOLEKAR R, NICOLAIDES KH: Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus. Clin Chem 57: 609-613, 2011.","DOI":"10.1373\/clinchem.2010.159806"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"GHOSHAL K, BHATTACHARYYA M: Adiponectin: probe of the molecular paradigm associating diabetes and obesity. World J Diabetes 6: 151-166, 2015.","DOI":"10.4239\/wjd.v6.i1.151"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"GREENMAN Y, GOLANI N, GILAD S, YARON M, LIMOR R, STERN N: Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin Endocrinol (Oxf) 60: 382-388, 2004.","DOI":"10.1111\/j.1365-2265.2004.01993.x"},{"key":"ref15","unstructured":"GREGORASZCZUK EL, RAK A: Superactive human leptin antagonist reverses leptin-induced excessive progesterone and testosterone secretion in porcine ovarian follicles by blocking leptin receptors. J Physiol Pharmacol 66: 39-46, 2015."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"HAMADA M, ABE M, MIYAKE T, KAWASAKI K, TADA F, FURUKAWA S, MATSUURA B, HIASA Y, ONJI M: B cell-activating factor controls the production of adipokines and induces insulin resistance. Obesity 19: 1915-1922, 2011.","DOI":"10.1038\/oby.2011.165"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"HAYES AL, XU F, BABINEAU D, PATEL SR: Sleep duration and circulating adipokine levels. Sleep 34: 147-152, 2011.","DOI":"10.1093\/sleep\/34.2.147"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"KULINA GR, RAYFIELD EJ: The role of glucagon in the pathophysiology and management of diabetes. Endocr Pract 22: 612-621, 2016.","DOI":"10.4158\/EP15984.RA"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"LEWANDOWSKI KC, STOJANOVIC N, PRESS M, TUCK SM, SZOSLAND K, BIENKIEWICZ M, VATISH M, LEWINSKI A, PRELEVIC GM, RANDEVA HS: Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 50: 1033-1037, 2007.","DOI":"10.1007\/s00125-007-0610-7"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"LO JC, LJUBICIC S, LEIBIGER B, KERN M, LEIBIGER IB, MOEDE T, KELLY ME, CHATTERJEE BHOWMICK D, MURANO I, COHEN P, BANKS AS, KHANDEKAR MJ, DIETRICH A, FLIER JS, CINTI S, BL\u00dcHER M, DANIAL NN, BERGGREN PO, SPIEGELMAN BM: Adipsin is an adipokine that improves \u03b2 cell function in diabetes. Cell 158: 41-53, 2014.","DOI":"10.1016\/j.cell.2014.06.005"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"MASLOWSKA M, SNIDERMAN AD, GERMINARIO R, CIANFLONE K: ASP stimulates glucose transport in cultured human adipocytes. Int J Obes Relat Metab Disord 21: 261-266, 1997.","DOI":"10.1038\/sj.ijo.0800396"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"MEHTA NN, MCGILLICUDDY FC, ANDERSON PD, HINKLE CC, SHAH R, PRUSCINO L, TABITA-MARTINEZ J, SELLERS KF, RICKELS MR, REILLY MP: Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59: 172-181, 2010.","DOI":"10.2337\/db09-0367"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"MOSCAVITCH SD, KANG HC, FILHO RA, MESQUITA ET, NETO HC, ROSA ML: Comparison of adipokines in a cross-sectional study with healthy overweight, insulin-sensitive and healthy lean, insulin-resistant subjects, assisted by a family doctor primary care program. Diabetol Metab Syndr 8: 9, 2016.","DOI":"10.1186\/s13098-016-0125-9"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"NASRAT H, PATRA SK, GOSWAMI B, JAIN A, RAGHUNANDAN C: Study of association of leptin and insulin resistance markers in patients of PCOS. Indian J Clin Biochem 31: 104-107, 2016.","DOI":"10.1007\/s12291-015-0499-8"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"OSEGBE I, OKPARA H, AZINGE E: Relationship between serum leptin and insulin resistance among obese Nigerian women. Ann Afr Med 15: 14-19, 2016.","DOI":"10.4103\/1596-3519.158524"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"RASK E, OLSSON T, S\u00d6DERBERG S, HOLST JJ, TURA A, PACINI G, AHR\u00c9N B: Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Metabolism 53: 624-631, 2004.","DOI":"10.1016\/j.metabol.2003.11.011"},{"key":"ref27","unstructured":"RAVN P: New paradigms in PCOS: impaired glucose tolerance and cardiovascular risk. Clinical approach. Minerva Ginecol 67: 217-223, 2015."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"RIZK NM, SHARIF E: Leptin as well as free leptin receptor is associated with polycystic ovary syndrome in young women. Int J Endocrinol 2015: 927805, 2015.","DOI":"10.1155\/2015\/927805"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"SEOW KM, JUAN CC, WU LY, HSU YP, YANG WM, TSAI YL, HWANG JL, HO LT: Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. Hum Reprod 19: 48-53, 2004.","DOI":"10.1093\/humrep\/deh010"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"SEOW KM, JUAN CC, HO LT, HSU YP, LIN YH, HUANG LW, HWANG JL: Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome. Hum Reprod 22: 1100-1106, 2007.","DOI":"10.1093\/humrep\/del489"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"SEPILIAN VP, CROCHET JR, NAGAMANI M: Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens. Fertil Steril 85: 1441-1447, 2006.","DOI":"10.1016\/j.fertnstert.2005.10.038"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"SPRANGER J, KROKE A, M\u00d6HLIG M, BERGMANN MM, RISTOW M, BOEING H, PFEIFFER AF: Adiponectin and protection against type 2 diabetes mellitus. Lancet 361: 226-228, 2003.","DOI":"10.1016\/s0140-6736(03)12255-6"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"THOMAS S, SURESH S, SUDHEESH M, VIJAYAKUMAR T: Association of insulin resistance with adipocytokine levels in patients with metabolic syndrome. Indian J Clin Biochem 30: 155-160, 2015.","DOI":"10.1007\/s12291-014-0423-7"},{"key":"ref34","unstructured":"VERHULST PJ, DEPOORTERE I: Ghrelin's second life: from appetite stimulator to glucose regulator. World J Gastroenterol 18: 3183-3195, 2012."},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"VOLLMER K, HOLST JJ, BALLER B, ELLRICHMANN M, NAUCK MA, SCHMIDT WE, MEIER JJ: Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 57: 678-687, 2008.","DOI":"10.2337\/db07-1124"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"WEI J, GAO J, CHENG J: Gestational diabetes mellitus and impaired glucose tolerance pregnant women. Pak J Med Sci 30: 1203-1208, 2014.","DOI":"10.12669\/pjms.306.5755"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"YADAV A, KATARIA MA, SAINI V, YADAV A: Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 417: 80-84, 2013.","DOI":"10.1016\/j.cca.2012.12.007"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"YASRUEL Z, CIANFLONE K, SNIDERMAN AD, ROSENBLOOM M, WALSH M, RODRIGUEZ MA: Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 26: 495-499, 1991.","DOI":"10.1007\/bf02536592"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"ZHANG F, TANG X, CAO H, L\u00dc Q, LI N, LIU Y, ZHANG X, ZHANG Y, CAO M, WAN J, AN Z, TONG N: Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance. Int J Med Sci 9: 574-581, 2012.","DOI":"10.7150\/ijms.4128"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T00:05:26Z","timestamp":1665273926000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomed.cas.cz\/physiolres\/pdf\/66\/66_283.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,16]]},"references-count":40,"URL":"https:\/\/doi.org\/10.33549\/physiolres.933366","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,16]]}}}